These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26549110)

  • 1. TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling.
    Park SA; Kim MJ; Park SY; Kim JS; Lim W; Nam JS; Yhong Sheen Y
    Sci Rep; 2015 Nov; 5():16492. PubMed ID: 26549110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.
    Kim MJ; Park SA; Kim CH; Park SY; Kim JS; Kim DK; Nam JS; Sheen YY
    Cell Physiol Biochem; 2016; 38(2):571-88. PubMed ID: 26845171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Dig Dis Sci; 2016 Sep; 61(9):2568-77. PubMed ID: 27074919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
    Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
    Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoviolanthin Extracted from
    Xing S; Yu W; Zhang X; Luo Y; Lei Z; Huang D; Lin J; Huang Y; Huang S; Nong F; Zhou C; Wei G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882900
    [No Abstract]   [Full Text] [Related]  

  • 14. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yao WL; Ko BS; Liu TA; Liang SM; Liu CC; Lu YJ; Tzean SS; Shen TL; Liou JY
    Anticancer Agents Med Chem; 2014 Jan; 14(1):29-34. PubMed ID: 23855336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion.
    Ramezani-Moghadam M; Wang J; Ho V; Iseli TJ; Alzahrani B; Xu A; Van der Poorten D; Qiao L; George J; Hebbard L
    J Biol Chem; 2015 Feb; 290(9):5533-42. PubMed ID: 25575598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3.
    Fan L; Zhu H; Tao W; Liu L; Shan X; Zhao M; Sun D
    Phytomedicine; 2019 Sep; 62():152931. PubMed ID: 31085375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway.
    Guo D; Zhang D; Ren M; Lu G; Zhang X; He S; Li Y
    FASEB J; 2020 Aug; 34(8):10668-10681. PubMed ID: 32567740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garcimultiflorone K from Garcinia multiflora attenuates hepatocellular carcinoma metastasis by suppressing transforming growth factor-β signaling.
    Huang SF; Wang YL; Chen JJ; Huang YB; Tai SB; Chung CL; Chen CL
    Phytomedicine; 2021 Apr; 84():153502. PubMed ID: 33647775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.